Virginia invests $67M in biotech

Virginia announced $66.7 million in grants for three projects within the life sciences, biotech and pharmaceutical industries, nrvnews.com reported Feb. 15.

Advertisement

The three grant recipients:

  1. Charlottesville-based University of Virginia’s Institute for Biotechnology will receive $36 million to accelerate drug discovery technologies. The grant is designed to attract 150 research scientists.
  2. The city of Roanoke will receive $15.7 million to create an incubator for new biotechnology companies across Southwestern Virginia.
  3. The Virginia Biotechnology Research Partnership Authority will receive $15 million to build a new life sciences building in Richmond.

“Life sciences are a critical sector for Virginia and a strategic target for growth in the Governor’s ‘Compete to Win’ Agenda for Economic Development,” Secretary of Commerce and Trade Caren Merrick said. “More than 150,000 Virginians are employed in the life sciences industry, and these new investments will spur additional growth and secure the Commonwealth’s leadership position in these sectors.”

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The hidden cost of lost clinical time and how leading health systems are responding

Friday, August 7
12:00 PM - 1:00 PM CDT

Presenters: Kassaundra McKnight-Young, Zebra TechnologiesGregory Carras, Zebra TechnologiesJennifer Gene, Levata

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.